Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease is a research paper published in Inflammatory Bowel Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: K08DK13121
NIDDK NIH HHS
Grant: RC2 DK118640
Crohn's & Colitis Foundation
Grant: 830997
NIDDK NIH HHS
Grant: K08 DK122133
NIDDK NIH HHS
Grant: RC2 DK122532
National Institute of Diabetes and Digestive Kidney Diseases
MeSH Terms
Keywords